PUBLISHER: Grand View Research | PRODUCT CODE: 2112232
PUBLISHER: Grand View Research | PRODUCT CODE: 2112232
The global prostate biopsy devices market size was valued at USD 839.0 million in 2025 and is projected to grow from USD 906.1 million in 2026 to USD 1,563.0 million by 2033, at a CAGR of 8.1% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 40.3% in 2025. The prostate biopsy device industry's growth is driven by the increasing prevalence of prostate disorders, growing awareness of the importance of early cancer detection, and rising adoption of advanced diagnostic technologies.
The shift toward minimally invasive biopsy procedures, coupled with improvements in imaging-guided techniques such as MRI-ultrasound fusion and transperineal biopsy, is enhancing diagnostic accuracy and patient safety. Favorable clinical guidelines promoting targeted biopsy approaches, expanding healthcare infrastructure, and greater access to urology services are further supporting market growth. In addition, continuous technological advancements, including disposable biopsy instruments, robotic-assisted systems, and precision-guided biopsy platforms, are improving procedural efficiency and clinical outcomes.
The rising prevalence of prostate cancer is a key factor driving the growth of the prostate biopsy device market, as an increasing number of men require confirmatory diagnostic procedures following suspicious screening results or clinical findings. Prostate biopsy remains the gold standard for obtaining tissue samples to confirm the presence and severity of cancer, making biopsy devices essential in the diagnostic pathway. As the incidence of prostate cancer continues to rise globally, healthcare providers are performing a greater volume of biopsy procedures to enable early diagnosis and appropriate treatment planning. The growing disease burden is also placing greater emphasis on accurate, efficient biopsy techniques that improve cancer detection and support better clinical outcomes. In addition, increasing prostate cancer diagnoses are encouraging healthcare facilities to expand their diagnostic capabilities and invest in advanced biopsy technologies, resulting in sustained demand for prostate biopsy devices.
Global Prostate Biopsy Device Market Report Segmentation
This report forecasts revenue growth at the global, regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the prostate biopsy device market report based on Product, procedure approach, imaging guidance technology, end user, and region: